TY - M-10263
AU - Adam, Lulu
AU - Tenga, Walter
TI - Quelling HIV: Enduring Antiretroviral Potency Amidst Initial Viremia and Its Absence
T2 - Scientific Research Journal of Medical and Health Science

PY - 2025
VL - 3
IS - 2
SN - 2584-1521

AB - When it comes to viremia, or measurable viral levels in the bloodstream, the Human Immunodeficiency Virus (HIV) remains a major concern for world health. Despite the revolutionary impact of antiretroviral medication (ART), obstacles to adherence, viral reservoirs, and resistant virus strains continue to pose a threat to HIV treatment. Whether or not initial viremia is present, this article investigates the long-term efficacy of antiretroviral therapy. Our research delves at the inner workings of the virus, how long-acting antiretroviral therapy (ART) affects patients, and possible approaches to attaining long-term viral suppression. Examining the current literature critically reveals new information on viral reservoirs, medicines that improve adherence, and changing treatment paradigms.

KW - HIV viremia
KW -  Antiretroviral therapy (ART)
KW -  Long-acting antiretroviral therapy (LA-ART)
KW -  Cabotegravir and rilpivirine
KW -  Viral reservoirs
KW -  Drug resistance
DO -